Literature DB >> 15188341

Prominent adverse effects of thalidomide in primary Sjögren's syndrome.

Stanley R Pillemer, Rose Anne Leakan, Vidya Sankar, Joan Manny, Bruce J Baum, Janine Smith, Usha Chaudhry, Philip C Fox, Lida Radfar, Sophie Ligier, Michael T Brennan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15188341     DOI： 10.1002/art.20416

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  8 in total

Review 1.  Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Antoni Sisó-Almirall; Xavier Bosch; Athanasios G Tzioufas
Journal:  Nat Rev Rheumatol       Date:  2012-05-01       Impact factor: 20.543

Review 2.  Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Authors:  B M Lodde; B J Baum; P P Tak; G Illei
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

Review 3.  Conventional therapy of Sjogren's syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 4.  T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Authors:  Gikas E Katsifis; Niki M Moutsopoulos; Sharon M Wahl
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

5.  Immunological consequences of thalidomide treatment in Sjögren's syndrome.

Authors:  N M Moutsopoulos; N Angelov; V Sankar; R A Leakan; S Pillemer; S M Wahl
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

6.  Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity.

Authors:  Weiming Luo; Qian-sheng Yu; Isidro Salcedo; Harold W Holloway; Debomoy K Lahiri; Arnold Brossi; David Tweedie; Nigel H Greig
Journal:  Bioorg Med Chem       Date:  2011-05-23       Impact factor: 3.641

7.  A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.

Authors:  David Tweedie; Weiming Luo; Ryan G Short; Arnold Brossi; Harold W Holloway; Yazhou Li; Qian-sheng Yu; Nigel H Greig
Journal:  J Neurosci Methods       Date:  2009-07-05       Impact factor: 2.390

8.  A Computational Text Mining-Guided Meta-Analysis Approach to Identify Potential Xerostomia Drug Targets.

Authors:  Micaela F Beckman; Elizabeth J Brennan; Chika K Igba; Michael T Brennan; Farah B Mougeot; Jean-Luc C Mougeot
Journal:  J Clin Med       Date:  2022-03-05       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.